Abaloparatide · source year

Abaloparatide research records in 2021

8 selected, source-linked Abaloparatide records carrying a 2021 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.

Dated records

8 selected records.

Evidence types

3 represented types.

Cited sources

8 distinct public records.

Explore 2021 by evidence type

3 types

Cited chronology

Abaloparatide records dated 2021

Open in the filterable feed →

December 2021

1 record

November 2021

1 record

Literature metadata

The use of abaloparatide to treat nonunion following dorsal closing wedge osteotomy for Freiberg's disease: A case report.

PubMed lists PMID 34786439 in Bone reports as Case Reports, Journal Article, with publication-date metadata of 2021-10-30 (day precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

October 2021

1 record

September 2021

1 record

June 2021

1 record

Literature metadata

Abaloparatide followed by alendronate in women ≥80 years with osteoporosis: post hoc analysis of ACTIVExtend.

PubMed lists PMID 32665529 in Menopause (New York, N.Y.) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-10 (month precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

May 2021

1 record

March 2021

1 record

Literature metadata

Abaloparatide Real-World Patient Experience Study.

PubMed lists PMID 33778325 in JBMR plus as Journal Article, with publication-date metadata of 2021-02-04 (day precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

February 2021

1 record

Literature metadata

Erratum for Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study.

PubMed lists PMID 33615100 in JBMR plus as Published Erratum, with publication-date metadata of 2020-11-03 (day precision). PeptideScanner associated the retained record with the identity slug abaloparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗